n Cardiovascular Journal of South Africa - Eprosartan (Teveten) offers new opportunities to prevent a second stroke : drug trends in cardiology

Volume 16, Issue 1
  • ISSN : 1680-0745



Extracted from text ... 56 CARDIOVASCULAR JOURNAL OF SOUTH AFRICA Vol 16, No. 1, January/February 2005 Drug Trends Eprosartan (Teveten) offers new opportunities to prevent a second stroke A recent series of CME lectures on stroke prevention, conducted by Prof. Brian Rayner, Head of the Division of Hypertension, Groote Schuur Hospital, stressed the value of the established antihypertensive, eprosartan, in secondary stroke prevention in clinical practice. The lectures, sponsored by Solvay Pharmaceuticals, reflected also on the results of the MOSES study (MOrbidity and mortality after StrokE), which were presented at the XVIIth meeting of the European Society of Cardiology in Munich last year. 'The ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error